Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
ABX1100arobiotx.com · Low evidenceAro Biotherapeutics is a biotechnology company developing tissue-targeted genetic medicines using its proprietary Centyrin protein technology. The company creates Centyrin-RNA drug conjugates to precisely modulate gene targets in disease tissues for treating intractable diseases.
Parse Score